quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:15:00·18h
PRRelease
National Health Investors Inc. logo
Ryman Hospitality Properties Inc. (REIT) logo

NHI Announces CFO Succession Plan; John Spaid to Retire, Todd Siefert Named Successor

NHI· National Health Investors Inc.RHP· Ryman Hospitality Properties Inc. (REIT)
Real Estate
Original source

Companies

  • NHI
    National Health Investors Inc.
    Real Estate
  • RHP
    Ryman Hospitality Properties Inc. (REIT)
    Real Estate

Recent analyst ratings

  • Apr 10RHPUpdateMorgan Stanley$105.00
  • Jan 20NHIUpdateDeutsche Bank$85.00
  • Jan 6RHPUpdateBarclays$110.00
  • Oct 22RHPUpdateMorgan Stanley$92.00
  • Oct 1RHPUpdateCantor Fitzgerald$108.00
  • Oct 1NHIUpdateCantor Fitzgerald$90.00

Related

  • SEC18h
    National Health Investors Inc. filed SEC Form 8-K: Leadership Update
  • PR1d
    Blueprint acts as transaction advisor to National Health Investors, Inc. (NYSE: NHI) in its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC).
  • SEC2d
    Amendment: National Health Investors Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC2d
    National Health Investors Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
  • NEWS2d
    NHI Announces Sale of NHC Portfolio for $560 Million
  • INSIDER7d
    SEC Form 4 filed by Roth Michael Isor
  • INSIDER7d
    SEC Form 4 filed by Reed Colin V
  • INSIDER7d
    SEC Form 4 filed by Prather Robert S Jr
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022